An Oklahoma judge says the state’s ongoing opioid drug claim versus customer products huge Johnson & Johnson can progress.
District Judge Thad Balkman on Monday denied a movement from the offender’s attorneys asking him to end Oklahoma’s public-nuisance claim and guideline in favor of the New Brunswick, New Jersey-based business and its subsidiaries. The offenders submitted the motion recently after the state rested its case. The trial started May 28.
Business attorneys argued the state’s case is an improper usage of a public-nuisance claim, typically booked for disputes over property.
Oklahoma states the business helped fuel the opioid crisis in Oklahoma with an aggressive marketing campaign that overemphasized the effectiveness and understated the addiction risk of opioids. The state desires the business to pay to help relieve the opioid crisis.